HomeRYTM • NASDAQ
add
Rhythm Pharmaceuticals Inc
Previous close
$54.91
Day range
$51.84 - $55.40
Year range
$35.17 - $68.58
Market cap
3.22B USD
Avg Volume
481.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 41.83M | 72.61% |
Operating expense | 79.30M | 27.35% |
Net income | -43.29M | -3.99% |
Net profit margin | -103.50 | 39.76% |
Earnings per share | -0.72 | -2.86% |
EBITDA | -40.87M | -0.05% |
Effective tax rate | 0.21% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 320.56M | 16.21% |
Total assets | 392.27M | 17.89% |
Total liabilities | 227.72M | 39.72% |
Total equity | 164.55M | — |
Shares outstanding | 62.39M | — |
Price to book | 156.89 | — |
Return on assets | -27.29% | — |
Return on capital | -38.01% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -43.29M | -3.99% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Nov 2008
Headquarters
Website
Employees
226
